Now showing items 1-13 of 13

    • Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1984-07-10)
      Compositions for treating open-angle glaucoma comprising N,N-dimethylaminoethyl carbamate and method of treating ocular hypertension by topically administering such compound to the hypertensive eye.
    • Interactions of serotonin receptors and ethanol in the rat brain slice 

      Lau, Hiu Lui (Texas A&M University. Libraries, 1993)
      Alcoholism, which is characterized by chronic ethanol abuse, has caused enormous social and health problems. Investigation into the mechanism of ethanol intoxication should provide useful information for treatment and ...
    • Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1986-01-21)
      Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of a dopamine ...
    • Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma 

      Chiou, George C. Y.; Liu, Hsin-Kuang (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1985-06-04)
      Antiglaucoma compositions that contain enriched R-(+)-1-tert-butylamino-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-prop anol compared to the S-(-)-isomer and the ophthalmologically acceptable acid addition salts thereof ...
    • Studies on the control of aqueous humor dynamics using selected antiglaucoma and autonomic drugs 

      Liu, Hsin-Kuang (Texas A&M University. Libraries, 1981)
      A blue dextran perfusion method for in vivo aqueous humor dynamic studies in the anesthetized cat eye was developed. The rates of aqueous humor formation and aqueous humor outflow were monitored simultaneously and ...
    • Treating or preventing ocular inflammation or systemic imflammatory disease 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-08-31)
      A novel compound for controlling (treatment and prevention) of ocular inflammation or systemic inflammatory disease is disclosed. The compound, OB-186, is effective at both the early and late phases of inflammation. The ...
    • Treatment of low pressure glaucoma and ischemic retinal degeneration 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-10-12)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of metoclopramide and is ...
    • Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-11-30)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of droperidol and is useful ...
    • Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-10-12)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of loxapine and is useful for ...
    • Treatment of ocular hypertension and glaucoma with dopamine antagonists 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1988-09-20)
      Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of certain dopamine ...
    • Use of OB-101 to treat inflammation 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1994-09-06)
      A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the ...
    • Use of OB-101 to treat ocular inflammation 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-03-16)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of ...
    • Use of OB-104 to treat ocular inflammation 

      Chiou, George C. Y. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 1993-03-30)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.